TMDX has 36-month beta value of 1.88. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for TMDX is 31.48M, and currently, short sellers hold a 19.03% ratio of that float. The average trading volume of TMDX on April 18, 2024 was 705.43K shares.
TMDX) stock’s latest price update
The stock price of Transmedics Group Inc (NASDAQ: TMDX) has plunged by -5.84 when compared to previous closing price of 93.31, but the company has seen a -8.14% decline in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-15 that TransMedics (TMDX) reachead $91.82 at the closing of the latest trading day, reflecting no change compared to its last close.
TMDX’s Market Performance
TMDX’s stock has fallen by -8.14% in the past week, with a monthly rise of 18.47% and a quarterly rise of 11.70%. The volatility ratio for the week is 5.57% while the volatility levels for the last 30 days are 6.26% for Transmedics Group Inc The simple moving average for the past 20 days is 8.46% for TMDX’s stock, with a 21.35% simple moving average for the past 200 days.
Analysts’ Opinion of TMDX
Many brokerage firms have already submitted their reports for TMDX stocks, with Piper Sandler repeating the rating for TMDX by listing it as a “Overweight.” The predicted price for TMDX in the upcoming period, according to Piper Sandler is $95 based on the research report published on March 28, 2024 of the current year 2024.
JP Morgan gave a rating of “Overweight” to TMDX, setting the target price at $48 in the report published on August 02nd of the previous year.
TMDX Trading at 5.60% from the 50-Day Moving Average
After a stumble in the market that brought TMDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.81% of loss for the given period.
Volatility was left at 6.26%, however, over the last 30 days, the volatility rate increased by 5.57%, as shares surge +19.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.50% upper at present.
During the last 5 trading sessions, TMDX fell by -8.14%, which changed the moving average for the period of 200-days by +4.62% in comparison to the 20-day moving average, which settled at $81.72. In addition, Transmedics Group Inc saw 11.31% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TMDX starting from Hassanein Waleed H, who sale 12,000 shares at the price of $95.09 back on Apr 10 ’24. After this action, Hassanein Waleed H now owns 74,087 shares of Transmedics Group Inc, valued at $1,141,080 using the latest closing price.
Khayal Tamer I, the Chief Commercial Officer of Transmedics Group Inc, sale 15,512 shares at $90.45 during a trade that took place back on Apr 09 ’24, which means that Khayal Tamer I is holding 25,185 shares at $1,403,082 based on the most recent closing price.
Stock Fundamentals for TMDX
Current profitability levels for the company are sitting at:
- -0.12 for the present operating margin
- 0.64 for the gross margin
The net margin for Transmedics Group Inc stands at -0.1. The total capital return value is set at -0.04. Equity return is now at value -15.42, with -5.09 for asset returns.
Based on Transmedics Group Inc (TMDX), the company’s capital structure generated 0.79 points at debt to capital in total, while cash flow to debt ratio is standing at -0.03. The debt to equity ratio resting at 3.7. The interest coverage ratio of the stock is -2.66.
Currently, EBITDA for the company is 8.76 million with net debt to EBITDA at -7.11. When we switch over and look at the enterprise to sales, we see a ratio of 12.4. The receivables turnover for the company is 3.8for trailing twelve months and the total asset turnover is 0.34. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.30.
Conclusion
To put it simply, Transmedics Group Inc (TMDX) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
